Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: A systematic review and meta-analysis

Gastrointestinal Endoscopy

Volumn 79, Issue 6, 2014, Pages

  Navaneethan, Udayakumar ^a   Njei, Basile ^b   Venkatesh, Preethi G K ^a   Vargo, John J ^a   Parsi, Mansour A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; META ANALYSIS; NUMERICAL CHROMOSOME ABERRATION; POLYSOMY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SPECTRAL SENSITIVITY; SYSTEMATIC REVIEW; TETRASOMY; TRISOMY; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; DIFFERENTIAL DIAGNOSIS; INTRAHEPATIC BILE DUCT; PROCEDURES; REPRODUCIBILITY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; DIAGNOSIS, DIFFERENTIAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; REPRODUCIBILITY OF RESULTS;

EID: 84901188354     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2013.11.001     Document Type: Article

References (27)

1. G.J. Gores Cholangiocarcinoma: current concepts and insights Hepatology 37 2003 961 969
2. H. Malhi, and G.J. Gores Review article: the modern diagnosis and therapy of cholangiocarcinoma Aliment Pharmacol Ther 23 2006 1287 1296
3. B. Blechacz, and G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308 321
4. J.J. Tischendorf, H. Hecker, and M. Kruger et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study Am J Gastroenterol 102 2007 107 114
5. R. Chapman, J. Fevery, A. Kalloo American Association for the Study of Liver Diseases Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2010 660 678
6. S.L. Walker, and P.A. McCormick Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review Abdom Imaging 33 2008 14 17
7. T.H. Baron, G.C. Harewood, and A. Rumalla et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures Clin Gastroenterol Hepatol 2 2004 214 219
8. T.J. Weismuller, J. Wedemeyer, and S. Kubicka et al. The challenges in primary sclerosing cholangitis eaetiopathogenesis, autoimmunity, management and malignancy J Hepatol 48 suppl 1 2008 S38, e57
9. Trikudanathan G, Navaneethan U, Njei B, et al. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis - a systematic review and meta-analysis. Gastrointest Endosc. Epub 2013 Oct 17.
10. L.E. Moreno Luna, B. Kipp, and K.C. Halling et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures Gastroenterology 131 2006 1064 1072
11. B.R. Kipp, L.M. Stadheim, and S.A. Halling et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures Am J Gastroenterol 99 2004 1675 1681
12. E.G. Fritcher, B.R. Kipp, and K.C. Halling et al. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures Gastroenterology 136 2009 2180 2186
13. S.Y. Bangarulingam, E. Bjornsson, and F. Enders et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis Hepatology 51 2010 174 180
14. D. Moher, A. Liberati, J. Tetzlaff The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement Ann Intern Med 151 2009 W65 W94
15. S.G. Thompson, and J.T. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 2002 1559 1573
16. P. Whiting, A.S. Rutjes, and J.B. Reitsma et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
17. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
18. R.M. Harbord, M. Egger, and J.C. Sterne A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Stat Med 25 2006 3443 3457
19. P. Charatcharoenwitthaya, F.B. Enders, and K.C. Halling et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis Hepatology 48 2008 1106 1117
20. M.J. Levy, T.H. Baron, and A.C. Clayton et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures Am J Gastroenterol 103 2008 1263 1273
21. B.R. Kipp, E.G. Barr Fritcher, and A.C. Clayton et al. Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography J Mol Diagn 12 2010 780 786
22. E.G. Barr Fritcher, B.R. Kipp, and J.S. Voss et al. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma Am J Gastroenterol 106 2011 2023 2028
23. Barr Fritcher EG, Voss JS, Jenkins SM, et al. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy. Cancer Cytopathol. Epub 2013 Jul 9.
24. M. Rabinovitz, A.B. Zajko, and T. Hassanein et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures Hepatology 12 1990 747 752
25. S. Rizvi, and G.J. Gores Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma Gastroenterology 15 2013 doi:pii: S0016-5085(13)01460-1
26. T.O. Lankisch, J. Metzger, and A.A. Negm et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis Hepatology 53 2011 875 884
27. Navaneethan U, Gutierrez N, Venkatesh PG, et al. Lipidomic profile of bile in distinguishing benign and malignant biliary strictures. American College of Gastroenterlogy; Oct 11-16, 2013; San Diego, CA. Abstract.